Adaptimmune Therapeutics PLC
Biological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire
- PrincipalsChristopher James HillChief Financial Officer
- CompanyAdaptimmune Therapeutics PLCAbingdon, Oxfordshire
Adaptimmune Therapeutics PLC is an SEC-registered OTC-listed company (ticker ADAPY) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 1
Finance
Christopher James HillChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Christopher James Hill — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Adaptin Bio, Inc.Biological Products, (No Diagnostic Substances) · Charlotte, NC, US1 shared capabilityAdaptive Biotechnologies CorpBiological Products, (No Diagnostic Substances) · Seattle, WA, US1 shared capabilityAdma Biologics, Inc.Biological Products, (No Diagnostic Substances) · Ramsey, NJ, US1 shared capabilityBioadaptives, Inc.Pharmaceutical Preparations · Las Vegas, NV, US1 shared capabilityAcumen Pharmaceuticals, Inc.Biological Products, (No Diagnostic Substances) · Newton, MA, US1 shared capabilityAbpro Holdings, Inc.Biological Products, (No Diagnostic Substances) · New York, NY, US1 shared capabilityAdimmune Corporationpharmaceutical industry, biotechnology · Taichung, TW1 shared capabilityHemab Therapeutics Holdings, Inc.Biological Products, (No Diagnostic Substances) · Cambridge, MA, US1 shared capability